107 related articles for article (PubMed ID: 17698033)
1. Mahanine reverses an epigenetically silenced tumor suppressor gene RASSF1A in human prostate cancer cells.
Jagadeesh S; Sinha S; Pal BC; Bhattacharya S; Banerjee PP
Biochem Biophys Res Commun; 2007 Oct; 362(1):212-217. PubMed ID: 17698033
[TBL] [Abstract][Full Text] [Related]
2. Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells.
Agarwal S; Amin KS; Jagadeesh S; Baishay G; Rao PG; Barua NC; Bhattacharya S; Banerjee PP
Mol Cancer; 2013 Aug; 12(1):99. PubMed ID: 24001151
[TBL] [Abstract][Full Text] [Related]
3. Fluorescent epigenetic small molecule induces expression of the tumor suppressor ras-association domain family 1A and inhibits human prostate xenograft.
Sheikh KD; Banerjee PP; Jagadeesh S; Grindrod SC; Zhang L; Paige M; Brown ML
J Med Chem; 2010 Mar; 53(6):2376-82. PubMed ID: 20184324
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.
Boyanapalli SS; Li W; Fuentes F; Guo Y; Ramirez CN; Gonzalez XP; Pung D; Kong AN
Pharmacol Res; 2016 Dec; 114():175-184. PubMed ID: 27818231
[TBL] [Abstract][Full Text] [Related]
5. Mahanine inhibits growth and induces apoptosis in prostate cancer cells through the deactivation of Akt and activation of caspases.
Sinha S; Pal BC; Jagadeesh S; Banerjee PP; Bandyopadhaya A; Bhattacharya S
Prostate; 2006 Sep; 66(12):1257-65. PubMed ID: 16683271
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression.
Palakurthy RK; Wajapeyee N; Santra MK; Gazin C; Lin L; Gobeil S; Green MR
Mol Cell; 2009 Oct; 36(2):219-30. PubMed ID: 19854132
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of wild-type RASSF1A gene expression on proliferation of hepatocellular carcinoma QGY-7703 cells].
Rui L; Xue WJ; Li P; Wang ZW; Wang P; Li HX
Ai Zheng; 2008 Sep; 27(9):924-8. PubMed ID: 18799029
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of RASSF1A in Colon Cancer by Suppression of Angiogenesis Signaling and Akt Activation.
Blanchard TG; Lapidus R; Banerjee V; Bafford AC; Czinn SJ; Ahmed H; Banerjee A
Cell Physiol Biochem; 2018; 48(3):1259-1273. PubMed ID: 30045022
[TBL] [Abstract][Full Text] [Related]
9. The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells.
Kuzmin I; Gillespie JW; Protopopov A; Geil L; Dreijerink K; Yang Y; Vocke CD; Duh FM; Zabarovsky E; Minna JD; Rhim JS; Emmert-Buck MR; Linehan WM; Lerman MI
Cancer Res; 2002 Jun; 62(12):3498-502. PubMed ID: 12067994
[TBL] [Abstract][Full Text] [Related]
10. Impact of Natural Compounds on DNA Methylation Levels of the Tumor Suppressor Gene RASSF1A in Cancer.
Dammann RH; Richter AM; Jiménez AP; Woods M; Küster M; Witharana C
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039788
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas.
Arya AK; Bhadada SK; Singh P; Sachdeva N; Saikia UN; Dahiya D; Behera A; Bhansali A; Rao SD
Sci Rep; 2017 Jun; 7(1):3123. PubMed ID: 28600574
[TBL] [Abstract][Full Text] [Related]
12. Status of RASSF1A in uveal melanocytes and melanoma cells.
Calipel A; Abonnet V; Nicole O; Mascarelli F; Coupland SE; Damato B; Mouriaux F
Mol Cancer Res; 2011 Sep; 9(9):1187-98. PubMed ID: 21788308
[TBL] [Abstract][Full Text] [Related]
13. Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons.
Reu FJ; Leaman DW; Maitra RR; Bae SI; Cherkassky L; Fox MW; Rempinski DR; Beaulieu N; MacLeod AR; Borden EC
Cancer Res; 2006 Mar; 66(5):2785-93. PubMed ID: 16510600
[TBL] [Abstract][Full Text] [Related]
14. REX-1 Represses RASSF1a and Activates the MEK/ERK Pathway to Promote Tumorigenesis in Prostate Cancer.
Liu W; Xie A; Tu C; Liu W
Mol Cancer Res; 2021 Oct; 19(10):1666-1675. PubMed ID: 34183450
[TBL] [Abstract][Full Text] [Related]
15. Testis specific Y-like 5: gene expression, methylation and implications for drug sensitivity in prostate carcinoma.
Kumar SR; Bryan JN; Esebua M; Amos-Landgraf J; May TJ
BMC Cancer; 2017 Feb; 17(1):158. PubMed ID: 28235398
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene.
Li J; Wang F; Protopopov A; Malyukova A; Kashuba V; Minna JD; Lerman MI; Klein G; Zabarovsky E
Oncogene; 2004 Aug; 23(35):5941-9. PubMed ID: 15208682
[TBL] [Abstract][Full Text] [Related]
17. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells.
Hååg P; Bektic J; Bartsch G; Klocker H; Eder IE
J Steroid Biochem Mol Biol; 2005 Aug; 96(3-4):251-8. PubMed ID: 15982869
[TBL] [Abstract][Full Text] [Related]
19. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
[TBL] [Abstract][Full Text] [Related]
20. Disulfiram and its novel derivative sensitize prostate cancer cells to the growth regulatory mechanisms of the cell by re-expressing the epigenetically repressed tumor suppressor-estrogen receptor β.
Sharma V; Verma V; Lal N; Yadav SK; Sarkar S; Mandalapu D; Porwal K; Rawat T; Maikhuri JP; Rajender S; Sharma VL; Gupta G
Mol Carcinog; 2016 Nov; 55(11):1843-1857. PubMed ID: 26599461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
